← SynDRA
MRX-6313
SynDRA canonical compound SYN1472397 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | AXL | FLT3 | MERTK | TYRO3 |
| Mechanism of action | FLT3 inhibitor | MER tyrosine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- FLT3 INHIBITOR
- MER tyrosine kinase inhibitor
- MERTK INHIBITOR
Cross-references
Synonyms
- R6N
- UNC-2025
- UNC2025
- (1r,4r)-4-(2-(butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol
- CHEMBL3326006
- 4-[2-(butylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol
- UNC2025A
- SCHEMBL14854194
- SCHEMBL15978986
- SCHEMBL21797957
- BDBM350845
- BCP16544
- EX-A1030
- BDBM50055496
- MFCD28142874
- s9662
- AKOS025289796
- ZINC210464182
- ZINC249857461
- CS-3354
- SB16838
- NCGC00390618-01
- NCGC00482875-01
- AK171371
- AS-52179
- DA-44845
- HY-12344
- US9795606, B4
- B8016
- FT-0743029
- (1r,4r)-4-(2-(butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexan-1-ol
- 4-(2-(Butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexan-1-ol
- 4beta-[2-(Butylamino)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-7H-pyrrolo[2,3-d]pyrimidine-7-yl]cyclohexane-1alpha-ol
Look up MRX-6313 in the interactive SynDRA portal →